ABPI Member event
Cancer chemotherapy, disease registers and molecular diagnostics is at the centre of the Government's new Life Sciences Strategy. The ABPI has developed an effective and mutually beneficial relationship between Public Health England and the UK pharmaceutical industry working across these areas. We are pleased to invite ABPI members to a half-day workshop focused on working with Public Health England on the treatment of malignant disease.
Mary Ward House Conference Centre
5 - 7 Tavistrock Place
Tuesday 27 February 2018
9:30 - 14:30
With presentations from the PHE teams responsible for disease registration, data quality and assessment, the management of strategic partnerships and processing of requests for information from the Office of Data Release, this is a must attend event.
We have planned breakout sessions to explore potential opportunities for our members to work with Public Health England and to help shape the development of new programmes and reporting capabilities.
Who is it for?
The workshop is aimed at full member ABPI companies with an interest in learning more about the collection and analysis of evidence created via the treatment of patients in the NHS and what this might mean for claims of product value.